Semaglutide doesnt just magically melt away pounds
Due to the concern about the growing prevalence of unapproved GLP-1s on the market, the FDA issued warning letters to the following companies in December: The FDA warned the companies about potential violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act), even with the companies claiming some of their GLP-1 products were currently for research purposes only
Others, like Louisiana's, don't cover Wegovy at all but cover an old weight loss drug, Orlistat, which is considered less effective
If you take other medications for diabetes, such as insulin or sulfonylureas, the risk of low blood sugar increases significantly
If you are considering compounded semaglutide from PlexusDx, discussing both medication storage best practices and any relevant genetic or biomarker insights with your qualified healthcare provider strengthens the foundation for safe, effective treatment